Notice2022-23068
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
October 24, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 204 (Monday, October 24, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 204 (Monday, October 24, 2022)]
[Notices]
[Page 64242]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-23068]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Early Detection Research Network: Clinical Validation Centers
(U01) and Biomarker Characterization Centers (U2C).
Date: November 16, 2022.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W260, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Robert F. Gahl, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9606 Medical Center Drive, Room
7W260, Rockville, Maryland 20850, 240-276-7869, <a href="/cdn-cgi/l/email-protection#b5c7dad7d0c7c19bd2d4ddd9f5dbdcdd9bd2dac3"><span class="__cf_email__" data-cfemail="265449444354520841474e4a66484f4e08414950">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; A data resource for blood and marrow transplants and adoptive
cellular therapy research.
Date: November 17, 2022.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W602, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Delia Tang, M.D., Scientific Review Officer,
Resources Training and Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W602, Rockville, Maryland 20850, 240-276-6456,
<a href="/cdn-cgi/l/email-protection#0571646b62614568646c692b6b6c6d2b626a73"><span class="__cf_email__" data-cfemail="a2d6c3ccc5c6e2cfc3cbce8ccccbca8cc5cdd4">[email protected]</span></a>.
Name of Committee: National Cancer Institute Initial Review
Group; Cancer Centers Study Section (A).
Date: December 1-2, 2022.
Time: 10:30 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W530, Rockville, Maryland 20850 (Telephone
Conference Call).
Contact Person: Shamala K. Srinivas, Ph.D., Associate Director,
Office of Referral, Review, and Program Coordination, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W530, Rockville, Maryland 20850, 240-276-6442,
<a href="/cdn-cgi/l/email-protection#b8cbcb8d8b8fccf8d6d1d096dfd7ce"><span class="__cf_email__" data-cfemail="98ebebadabafecd8f6f1f0b6fff7ee">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: October 19, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-23068 Filed 10-21-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on October 24, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.